Circulating oxidized LDL and inflammation in extreme pediatric obesity

Anne L Norris1, Julia Steinberger, Lyn M Steffen

  • 1Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA.

Insights

Extreme pediatric obesity significantly elevates oxidative stress and inflammation markers like oxidized low-density lipoprotein (oxLDL) and C-reactive protein (CRP) in children. This suggests early cardiovascular disease and type 2 diabetes risks in this population.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Health
  • Metabolic Syndrome

Background:

  • Oxidative stress and inflammation are critical in obesity-related complications.
  • These factors are not well-characterized in extreme pediatric obesity.
  • Early identification of cardiovascular disease and type 2 diabetes mellitus risk factors is crucial in pediatric populations.

Purpose of the Study:

  • To compare circulating levels of oxidized low-density lipoprotein (oxLDL), C-reactive protein (CRP), and interleukin-6 (IL-6) in extremely obese (EO) children versus normal weight (NW) and overweight/obese (OW/OB) children.
  • To investigate the association between extreme pediatric obesity and markers of oxidative stress and inflammation.

Main Methods:

  • Cross-sectional study involving 225 children and adolescents (age 13.5 ± 2.5 years).
  • Participants classified into NW (<85th BMI percentile), OW/OB (85th to <1.2 times 95th percentile), and EO (≥1.2 times 95th percentile or BMI ≥35 kg/m²).
  • Measured oxLDL, CRP, IL-6, BMI, blood pressure, and fasting glucose, insulin, and lipids; analyzed using analysis of covariance adjusted for gender, age, and race.

Main Results:

  • Blood pressure, insulin, and lipids worsened significantly across BMI groups (P < 0.0001).
  • Oxidized low-density lipoprotein (oxLDL) and C-reactive protein (CRP) levels were significantly higher in EO children compared to NW and OW/OB groups (P < 0.01).
  • Interleukin-6 (IL-6) was significantly higher in EO children compared to NW and OW/OB groups (P < 0.0001), but not different between NW and OW/OB.

Conclusions:

  • Extreme pediatric obesity is associated with significantly higher levels of oxidative stress and inflammation compared to milder obesity and normal weight.
  • These findings suggest that early markers of cardiovascular disease and type 2 diabetes mellitus are present in extremely obese children.
  • This highlights the need for early intervention and management strategies for extreme pediatric obesity.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Inflammation01:38

Inflammation

Overview
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...